HEALTHYWAY INC (02587) has unveiled its interim financial results for the six-month period ended June 30, 2026, recording a significant uptick in both revenue and profitability.
The company reported total revenue of RMB 775 million for the period, representing a robust 49.72% growth compared to the corresponding period last year. Meanwhile, net profit attributable to equity shareholders climbed 29.65% year-on-year to RMB 9.161 million. The company posted basic earnings per share of RMB 0.01 during the review period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments